SHANGHAI, Nov 15 (Reuters) - Procter & Gamble Co. (PG.N) will start reintroducing its SK-II skincare line into Chinese stores early next month after suspending sales for more than two months because authorities raised concerns about its safety.
SK-II sales will resume in a limited number of department stores in major cities, and the company will offer a counseling service with the products as it works to regain the trust of customers, the U.S. consumer products giant said on Wednesday.
The firm halted sales of SK-II, previously one of its biggest cosmetics lines in China, and offered refunds to buyers after Beijing’s product quality watchdog said it had detected chromium and neodymium in some products, prompting a storm of negative comment in the local press.
Chinese regulators subsequently stated the products were safe to use, and P&G announced in late October that it would resume Chinese sales of SK-II “within weeks”.
SK-II sales were also suspended in South Korea for about two weeks but resumed there after the country’s Food and Drug Administration said the products were safe.